ASX:OPT

Opthea Limited (OPT.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

A$2.87

MA: A$2.87▼

A$2.87

52-Week Range N/A

Volume504,572 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3 for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Overall MarketRank^™

0.52 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Opthea Limited (OPT.AX).

2.6 Community Rank

Outperform Votes
Opthea Limited (OPT.AX) has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Opthea Limited (OPT.AX) has received 17 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Opthea Limited (OPT.AX) has received 51.43% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Opthea Limited (OPT.AX) and other stocks. Vote “Outperform” if you believe OPT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OPT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Opthea Limited (OPT.AX) does not currently pay a dividend.
Dividend Growth
Opthea Limited (OPT.AX) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Opthea Limited (OPT.AX) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ASX

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolASX:OPT

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.opthea.com

Phone61 3 9826 0399

EmployeesN/A

Debt

Debt-to-Equity Ratio0.41

Current Ratio10.31

Quick Ratio10.24

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$149,575.00

Price / Sales0.00

Cash FlowN/A

Price / Cash Flow10.29

Book ValueA$0.24 per share

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive OPT News and Ratings via Email

Sign-up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter.

Opthea Limited (OPT.AX) (ASX:OPT) Frequently Asked Questions

What stocks does MarketBeat like better than Opthea Limited (OPT.AX)?

Wall Street analysts have given Opthea Limited (OPT.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Opthea Limited (OPT.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Opthea Limited (OPT.AX)'s earnings last quarter?

Opthea Limited (OPT.AX) (ASX:OPT) released its earnings results on Friday, August, 9th. The company reported ($0.09) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.09) by $0.00.
View Opthea Limited (OPT.AX)'s earnings history.

Who are some of Opthea Limited (OPT.AX)'s key competitors?

Some companies that are related to Opthea Limited (OPT.AX) include Antisense Therapeutics Limited (ANP.AX) (ANP), Bayer Aktiengesellschaft (BAYN.F) (BAYN), Mayne Pharma Group (MAYNF), Mayne Pharma Group Limited (MYX.AX) (MYX), Medical Developments International Limited (MVP.AX) (MVP), Otsuka (OTSKY), Patrys Limited (PAB.AX) (PAB), Pharmaxis Ltd (PXS.AX) (PXS), Recce Pharmaceuticals Ltd (RCE.AX) (RCE), Roche (RHHVF), Sanofi (SAN.PA) (SAN), Sinclair Pharma plc (SPH.L) (SPH) and Vita Life Sciences Limited (VLS.AX) (VLS).
View all of OPT's competitors.

What other stocks do shareholders of Opthea Limited (OPT.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Opthea Limited (OPT.AX) investors own include The Walt Disney (DIS), Datadog (DDOG), salesforce.com (CRM), (CGC), (BRK.B) (BRK.B), (AZN), American Water Works (AWK), Activision Blizzard (ATVI), Appian (APPN) and Advanced Micro Devices (AMD).

Who are Opthea Limited (OPT.AX)'s key executives?

Opthea Limited (OPT.AX)'s management team includes the following people:

Dr. Megan Baldwin M.A.I.C.D., Ph.D., MAICD, MD, CEO & Exec. Director (Age 46, Pay $591.3k)
Mr. Michael Tonroe B.Sc., F.C.A., M.A.I.C.D., Bsc(Hons), ACA, MAICD, CFO & Company Sec. (Age 54, Pay $351.56k)
Ms. Annie Lee, Fin. & Operations Mang.
Dr. Richard Chadwick, Head of Intellectual Property (Age 54)
Dr. Michael Gerometta, Head of Chemistry, Manufacturing & Controls Devel. (Age 56)
Dr. Ian Leitch, Director of Clinical Research (Age 57)
Dr. James Goding, Independent Consultant

What is Opthea Limited (OPT.AX)'s stock symbol?

Opthea Limited (OPT.AX) trades on the ASX under the ticker symbol "OPT."

How big of a company is Opthea Limited (OPT.AX)?

Opthea Limited (OPT.AX) has a market capitalization of $0.00 and generates $149,575.00 in revenue each year.

What is Opthea Limited (OPT.AX)'s official website?

The official website for Opthea Limited (OPT.AX) is www.opthea.com.

How can I contact Opthea Limited (OPT.AX)?

The company can be reached via phone at 61 3 9826 0399.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Opthea Limited (OPT.AX) Stock Forecast, Price & News

Adding

Adding

Adding Opthea Limited (OPT.AX)

MarketRank™

Overall MarketRank™